• Home
  • ABOUT
    • Leadership Team
    • Scientific Group Leaders
    • Alumni
    • Our Philosophy
  • Services
    • Animal Models
    • Translatability & Advanced Technologies
    • Histopathology Services
  • PUBLICATIONS
  • NEWS
  • Contact
REQUEST A QUOTE
  • Home
  • ABOUT
    • Leadership Team
    • Scientific Group Leaders
    • Alumni
    • Our Philosophy
  • Services
    • Services – Animal Models
    • Services – Translatability and Advanced Technologies
    • Histopathology Services
  • Publications
  • News
  • Contact
  • Request A Quote

MatrileX Highlights Preclinical Rigor Strategies in Fibrosis Research at the 9th AFDD Summit

by admin | Dec 3, 2025 | News

At the 9th Antifibrotic Drug Development Summit, Dr. Yanling Zhang presented MatrileX’s research poster, “Back to the Future: Using Clinical Trial Design to Enhance the Utility of Preclinical Testing in Fibrotic Diseases.” The poster highlights strategies to...

Professor Richard E. Gilbert Co-Chairs Key Sessions at the 9th AFDD Summit

by admin | Dec 3, 2025 | News

Boston, MA — November 17–19, 2025 — MatrileX Laboratories participated in the 9th Antifibrotic Drug Development Summit, a leading industry forum bringing together experts across fibrosis biology, translational research, and early clinical development. Co-Chair of...

5W10, Li Ka Shing Knowledge Institute
St. Michael’s Hospital, Unity Health Toronto
209 Victoria Street, Toronto
ON M5B 1T8 Canada

ABOUT

Leadership Team
Scientific Group Leaders
Alumni
Our Philosophy

SERVICES

Animal Models
Translatability & Advanced Technologies
Histopathology Services

CONTACT

Contact

Book a consultation